What the scientists say about Kia’s new product: Optima recalls after the best melatonin in the world

Optima has recalled its melatonin pill after it was found to contain a form of an antibiotic known as amoxicillin-resistant Staphylococcus aureus (MRSA).

Kia has issued a statement to The Register saying it is “extremely concerned” by the recall and will be contacting customers.

The company has also issued a recall alert on its website for those who purchased the product between January 20 and March 1.

This means Kia is recalling all of its products made from April 1, 2019.

“We have identified the ingredient that was in this product and we are taking the appropriate action to ensure it is removed from our supply,” Kia said.

“Customers should not consume this product.”

This means that all Kia products made on or after April 1 will contain the antibiotic amoxicillin-resistance Staph, the product’s makers have said.

Kia also said it will not be able to provide advice on how to safely use the product.

“This product contains antibiotics, and we do not recommend its use to people with any medical condition,” the statement read.

“There are no adverse reactions reported to date.

We encourage people to contact their GP if they have any concerns about this product or any other Kia product.”

A spokesperson for Kia told The Register that the company was working with the Food and Drug Administration and Health Canada to investigate the cause of the issue.

“Kia is currently investigating the situation,” she said.

“We will provide any additional information that is required at the appropriate time.”